Tyra Biosciences, Inc.
TYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$86,481 | -$69,134 | -$55,325 | -$26,294 |
| Dep. & Amort. | $519 | $353 | $296 | $140 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $22,801 | $0 | $0 | $2,887 |
| Change in WC | -$729 | $6,360 | -$5,847 | -$481 |
| Other Non-Cash | -$5,884 | $12,282 | $10,591 | $3 |
| Operating Cash Flow | -$69,774 | -$50,139 | -$50,285 | -$23,745 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$664 | -$770 | -$559 | -$661 |
| Net Acquisitions | $0 | $0 | $0 | $16 |
| Inv. Purchases | -$263,624 | -$143,835 | $0 | $0 |
| Inv. Sales/Matur. | $165,885 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$98,403 | -$144,605 | -$559 | -$645 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$9 |
| Stock Issued | $200,000 | $1,537 | $632 | $181,220 |
| Stock Repurch. | -$420 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,557 | $0 | $0 | $130,137 |
| Financing Cash Flow | $202,137 | $1,537 | $632 | $311,348 |
| Forex Effect | $0 | $0 | -$757 | $0 |
| Net Chg. in Cash | $33,960 | -$193,207 | -$50,969 | $286,958 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59,006 | $251,213 | $302,182 | $15,467 |
| End Cash | $92,966 | $58,006 | $251,213 | $302,425 |
| Free Cash Flow | -$70,438 | -$50,909 | -$50,844 | -$24,406 |